** Shares of Schott Pharma 1SXP.DE rise 6.4% in early Frankfurt trade after the pharmaceuticals packaging manufacturer's Q1 results came in slightly above expectations
** Quarterly sales were 240 million euros, ($286 million) beating the Jefferies consensus estimtate of 231 million euros and rising by 3.8%
** A local trader also says that there might be some reallocations from Schott Pharma's rival Gerresheimer GXIG.DE which warned that an accounting probe may hit 2025 results
($1 = 0.8395 euros)
(Reporting by Simon Ferdinand Eibach)
((Simonferdinand.eibach@thomsonreuters.com))